Literature DB >> 6622739

Kurt Schneider's 'Zwischen-Fälle', 'mid-cases' or 'cases in between'.

A Marneros.   

Abstract

Kurt Schneider's concept recognizes an intermediate area between the two groups of the major psychoses: the 'Zwischen-Fälle', in translation 'mid-cases' or 'cases in between'. We investigated 108 such cases, and we found that some features external to the symptomatology distinguished the 'mid-cases' or the 'cases in between' from schizophrenia and suggested particular similarities to the affective psychoses. Such external factors were: age, heredity, educational and occupational level, broken home situation, life events, and necessity for long hospitalization.

Entities:  

Mesh：

Year:  1983        PMID： 6622739

Source DB:  PubMed          Journal:  Psychiatr Clin (Basel)        ISSN： 0033-264X


  4 in total

1.  Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. I. Definitions, methods, psychopathological and social outcome.

Authors:  A Marneros; A Deister; A Rohde; E M Steinmeyer; H Jünemann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

2.  Frequency of occurrence of Schneider's first rank symptoms in Schizophrenia.

Authors:  A Marneros
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

3.  Schizophrenia suspecta.

Authors:  A Marneros; A Deister; N Diederich; A Rohde
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

4.  Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.

Authors:  Konstantinos N Fountoulakis; Elena Dragioti; Antonis T Theofilidis; Tobias Wikilund; Xenofon Atmatzidis; Ioannis Nimatoudis; Erik Thys; Martien Wampers; Luchezar Hranov; Trayana Hristova; Daniil Aptalidis; Roumen Milev; Felicia Iftene; Filip Spaniel; Pavel Knytl; Petra Furstova; Tiina From; Henry Karlsson; Maija Walta; Raimo K R Salokangas; Jean-Michel Azorin; Justine Bouniard; Julie Montant; Georg Juckel; Ida S Haussleiter; Athanasios Douzenis; Ioannis Michopoulos; Panagiotis Ferentinos; Nikolaos Smyrnis; Leonidas Mantonakis; Zsófia Nemes; Xenia Gonda; Dora Vajda; Anita Juhasz; Amresh Shrivastava; John Waddington; Maurizio Pompili; Anna Comparelli; Valentina Corigliano; Elmars Rancans; Alvydas Navickas; Jan Hilbig; Laurynas Bukelskis; Lidija Injac Stevovic; Sanja Vodopic; Oluyomi Esan; Oluremi Oladele; Christopher Osunbote; Janusz Κ Rybakowski; Pawel Wojciak; Klaudia Domowicz; Maria Luisa Figueira; Ludgero Linhares; Joana Crawford; Anca-Livia Panfil; Daria Smirnova; Olga Izmailova; Dusica Lecic-Tosevski; Henk Temmingh; Fleur Howells; Julio Bobes; Maria Paz Garcia-Portilla; Leticia García-Alvarez; Gamze Erzin; Hasan Karadağ; Avinash De Sousa; Anuja Bendre; Cyril Hoschl; Cristina Bredicean; Ion Papava; Olivera Vukovic; Bojana Pejuskovic; Vincent Russell; Loukas Athanasiadis; Anastasia Konsta; Dan Stein; Michael Berk; Olivia Dean; Rajiv Tandon; Siegfried Kasper; Marc De Hert
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.